We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

43 hedge funds and large institutions have $118M invested in Spruce Biosciences in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

5% more funds holding

Funds holding: 41 → 43 (+2)

13% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 16

48% less capital invested

Capital invested by funds: $225M → $118M (-$107M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
6
Increased
14
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$1.28M
2
Renaissance Technologies
Renaissance Technologies
New York
+$284K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$204K
4
Millennium Management
Millennium Management
New York
+$179K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$161K

Top Sellers

Rank Fund Capital Flow
1
Sands Capital Management
Sands Capital Management
Virginia
-$8.82M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.96M
4
CCM
CAAS Capital Management
New York
-$543K
5
Morgan Stanley
Morgan Stanley
New York
-$391K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$146K +$204K +325 New
Two Sigma Advisers
27
Two Sigma Advisers
New York
$115K +$161K +256 New
Charles Schwab
28
Charles Schwab
California
$111K -$207K -330 -57%
State Board of Administration of Florida Retirement System
29
State Board of Administration of Florida Retirement System
Florida
$105K +$146K +233 New
Bank of America
30
Bank of America
North Carolina
$102K +$74.7K +119 +113%
Goldman Sachs
31
Goldman Sachs
New York
$78K +$18.2K +29 +20%
TI
32
Trexquant Investment
Connecticut
$72K +$100K +160 New
LCM
33
Laurion Capital Management
New York
$68K -$30.1K -48 -24%
Wells Fargo
34
Wells Fargo
California
$66K +$32.6K +52 +55%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$37K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$30K -$1.26K -2 -3%
AIG
37
American International Group
New York
$29K -$1.26K -2 -3%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$28K -$61.5K -98 -61%
TRCT
39
Tower Research Capital (TRC)
New York
$20K +$19.5K +31 +258%
Citigroup
40
Citigroup
New York
$8K +$7.53K +12 +200%
Legal & General Group
41
Legal & General Group
United Kingdom
$5K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$5K +$2.51K +4 +50%
AIP
43
Ameritas Investment Partners
Nebraska
$4K – – –
Sands Capital Management
44
Sands Capital Management
Virginia
– -$8.82M -10,493 Closed
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
– -$2.7M -3,207 Closed
Alyeska Investment Group
46
Alyeska Investment Group
Illinois
– -$218K -259 Closed
SO
47
STRS Ohio
Ohio
– -$26K -32 Closed
1
2

SPRB Hedge Fund Activity: Q3 2021 in Review

43 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q3 2021, worth a combined $118M — down 48% from $225M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SPRB positions and 4 closed out — a net gain of 2 holders — while 14 added to existing stakes and 16 trimmed.

The largest buyer was Deerfield Management, adding an estimated $1.28M. The largest seller was Sands Capital Management, exiting entirely with an estimated $8.82M sold.

  • 43 institutional investors held Spruce Biosciences (SPRB) as of Q3 2021, up from 41 in Q2 2021.
  • Funds reported $118M of Spruce Biosciences stock for Q3 2021, down 48% quarter-over-quarter.
  • 6 funds opened new Spruce Biosciences positions in Q3 2021 and 4 closed out, a net change of +2 holders.
  • The largest Spruce Biosciences buyer in Q3 2021 was Deerfield Management, an estimated $1.28M added.
  • The largest Spruce Biosciences seller in Q3 2021 was Sands Capital Management, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2021.